Dr. Manogna Nookathota, MD

Dr. Nookathota practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Nookathota's NPI, 1538575097, was assigned on July 5, 2014. Dr. Nookathota holds New Mexico license MD2022-0086.

Dr. Nookathota's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Nookathota's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Nookathota to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nookathota practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Nookathota's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Nookathota's licenses on file in 3 states: New Mexico, Illinois and Nebraska.

CMS data shows 309 Medicare services from Dr. Nookathota across 3 procedure codes in 2024, for 95 Medicare patients. Medicare paid $19,817 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Nookathota in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nookathota's median patient age at 63, with 50% women.

In 2024, Dr. Nookathota wrote 150 Medicare Part D claims for 63 patients. 89% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $91 in total drug cost. In 2020, CMS named 45 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Nookathota for performance year 2024, reported as part of a group. Dr. Nookathota accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Nookathota from 3 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $54.